Safety and Efficacy of Intrathecal Rituximab in 16 Children of Stage Ⅲ、ⅣNon-Hodgkin Lymphoma
NCT06190457
·
clinicaltrials.gov ↗
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma, Non-Hodgkin
Child, Only
Interventions
OTHER:
intrathecal rituximab
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University